Medicine
Permanent URI for this communityhttp://repository.kln.ac.lk/handle/123456789/12
This repository contains the published and unpublished research of the Faculty of Medicine by the staff members of the faculty
Browse
4 results
Search Results
Item Spatial epidemiologic trends and hotspots of leishmaniasis, Sri Lanka, 2001-2018(Centers for Disease Control and Prevention (CDC), 2020) Karunaweera, N.D.; Ginige, S.; Senanayake, S.; Silva, H.; Manamperi, N.; Samaranayake, N.; Siriwardana, Y.; Gamage, D.; Senerath, U.; Zhou, G.;ABSTRACT: Leishmaniasis, a neglected tropical disease, is on the decline in South Asia. However, cases of cutaneous leishmaniasis have risen in Sri Lanka since 2001, and the lack of in-depth research on its epidemiologic characteristics hampers control efforts. We analyzed data collected from patients with cutaneous leishmaniasis in Sri Lanka during 2001-2018 to study temporal and geographic trends and identify and monitor disease hotspots. We noted a progression in case rates, including a sharp rise in 2018, showing temporal expansion of disease-prevalent areas and 2 persistent hotspots. The northern hotspot shifted and shrank over time, but the southern hotspot progressively expanded and remained spatially static. In addition, we noted regional incidence differences for age and sex. We provide evidence of temporally progressive and spatially expanding incidence of leishmaniasis in Sri Lanka with distinct geographic patterns and disease hotspots, signaling an urgent need for effective disease control interventions. KEYWORDS: Asia; Indian subcontinent; Leishmania donovani; Sri Lanka; cutaneous leishmaniasis; dermatological pathologies; epidemiology; infectious diseases; leishmaniasis; parasites; protozoa; skin lesions; vector-borne infections.Item Clinical and histopathological characteristics of cutaneous leishmaniasis in a group of military personnel in Sri Lanka(American Society of Tropical Medicine and Hygiene, 2015) Manamperi, N.H.; Fernando, C.S.; Pathirana, A.; Abeyewickreme, W.; de Silva, V.C.; Karunaweera, N.D.Cutaneous leishmaniasis (CL) is a newly established vector-borne parasitic disease in Sri Lanka. Military personnel have an occupational risk for CL due to being stationed in endemic areas and exposure to vectors outdoors. This study describes the clinical and histopathological features of CL in a group of military personnel. Thirty five patients with smear positive for Leishmania amastigotes were included, their data analyzed for clinical features and skin biopsies processed routinely for histology, examined at a conference microscope and classified into 4 groups using modified Ridley criteria for Leishmaniasis as: I-parasitized macrophages with variable lymphocytes and plasma cells; II-parasitized macrophages with lymphocytes, plasma cells and ill formed histiocytic granulomata; III-a mixture of macrophages (with or without parasites), lymphocytes, plasma cells and epithelioid granulomata; IV-epithelioid granulomatous response with a few lymphocytes and plasma cells but no amastigotes. Lesions were categorized by duration, as acute (< 6 months) or chronic (> 6 months). Study group composed of all males with a mean age of 32.6 years (range 22-47) and lesion duration of 5.6 months (range 1-24). Number of lesions varied from 1 to 6 with majority (71.4%, n= 25) having a single lesion. Nodular (37.1%, n=13) and nodulo-ulcerative (25.7%, n=9) lesions in upper limbs (68.6%, n=24) was the commonest presentation. Twenty nine (82.9%) of the biopsies were positive also by histology. Twenty two (62.9%) were acute and 13 (37.1%) chronic. Group I, II, III and IV patterns were seen in 14 (40%), 12 (34.3%), 5 (14.3%) and 4 (11.4%) respectively and 9 (40.9%), 9 (40.9%), 2 (9.1%) and 2 (9.1%) of acute lesions and 5 (38.5%), 3 (23.1%), 3 (23.1%) and 2 (15.4%) of chronic lesions respectively. Necrosis was not seen in any of the lesions. Majority in this group of military personnel with CL had single lesions affecting the upper limbs and sought treatment within 2 years of appearance of lesions. The histological picture varied from diffuse infiltration of parasitized macrophages admixed with chronic inflammatory cells to ill-formed histiocytic granulomata.Item In situ immunopathological changes in cutaneous leishmaniasis due to Leishmania donovani(Oxford, Wiley, 2017) Manamperi, N.H.; Oghumu, S.; Pathirana, N.; de Silva, V.C.; Abeyewickreme, W.; Satoskar, A.R.; Karunaweera, N.D.INTRODUCTION: Cutaneous leishmaniasis in Sri Lanka is a newly established parasitic disease caused by the usually visceralizing Leishmania donovani. Skin lesions manifest as non-itchy, non-tender papules, nodules or ulcers. In situ cytokine expression provides clues for immunopathogenesis of this localized form of disease. METHODS: Skin biopsies from 58 patients were analyzed for histological appearance and in situ cytokine expression of T- helper 1 (Th1) and T- helper 2 (Th2) cytokines, namely interferon (IFN)-γ, interleukin (IL)-12A, tumor necrosis factor (TNF)-α, IL-4 and IL-10 by real-time RT- PCR. RESULTS: Significant up regulation of the Th1 cytokine IFN-γ and down regulation of the Th2 cytokine IL-4 was seen in patients compared to healthy controls. Significantly elevated tissue expression of IFN-γ and TNF-α was seen in lesions that presented later than 6 months from the time of onset, while IL-4 expression was more prominent in lesions that responded poorly to antimony therapy. CONCLUSION: A prominent Th1 response appears to support resolving of lesions, whereas a Th2 biased milieu tends to favor poor responsiveness to antimony and delayed lesion healing in L. donovani infections in Sri Lanka. This article is protected by copyright. All rights reserved.Item Clinical features of cutaneous leishmaniasis in Sri Lanka and molecular identification of L. donovani as the cause(Elsevier, 2008) Siriwardana, H.V.Y.D.; Noyes, H.A.; Beeching, N.J.; Wickremasinghe, A.R.; Chance, M.L.; Bates, P.A.; Karunaweera, N.D.BACKGROUND: Cutaneous leishmaniasis (CL) is a newly established disease in Sri Lanka with over 1500 locally acquired cases reported since year 2001. OBJECTIVES: To study the clinical profile, associated risk factors and genetic analysis of the causative parasite of CL in Sri Lanka. METHODOLOGY: Clinical evaluation was carried out on patients who visited the Department of Parasitology, Faculty of Medicine, Colombo for diagnosis using a pre-tested questionnaire. Light microscopy and/or PCR were performed on lesion material to confirm diagnosis. Formol gel test (FGT) was done on all patients. The causative species was identified by sequencing of the partial 6PGDH gene, followed by microsatellite analysis to study the phylogenetic relationships. RESULTS: There were 401 patients (78.9% males, out of which 57.4% were soldiers) with at least 549 lesions. Most infections were acquired in Northern (55.7%) or Southern (39.3%) Sri Lanka. Several lesion types were noted: papules 23.4%, nodules 25.4%, ulcerating nodules 19.6%, ulcers 23.7%, plaques 6.4% and other 1.7%. Nodules with 5–9 months duration had the highest parasite positivity (n = 100, 75.5%). Sporotrichoid spread (n = 44, 11.9%), satellite lesions (n = 35, 8.9%) and lymphatic spread (n = 109, 27.7%) were commonly observed. No patients had visceral features and the FGT was negative in all subjects. Male sex, 20–40 years of age and over 5 hours/day spent outdoors were identified as risk factors, but not household clustering. The causative species was identified as L. donovani, belonging to a distinct genetic group within that complex. CONCLUSIONS: A dermotrophic variant of L. donovani causes cutaneous leishmaniasis in Sri Lanka. The ability of the local Leishmania parasite to visceralize, self heal or develop drug resistance is yet to be determined. In spite of the generally accepted anthroponotic nature of L donovani, in this study favours zoonotic transmission of the local species. Acknowledgements: Mr. RL Ihalamulla, Mr. S Jayasinghe for technical assistance. Financial support for this study was from Sri Lanka National Science Foundation and the Commonwealth Scholarship Association. © 2008 Elsevier Inc.